diabetes mellitus | Research | Treatment | 10 pages | source: Lancet (London, England) | Added Nov 01, 2021
Effectiveness and safety of tirzepatide compared to insulin degludec in patients with type 2 diabetes.
This study compared the effectiveness and safety of tirzepatide to insulin degludec (Tresiba) in patients with uncontrolled type 2 diabetes (T2D). The data showed that tirzepatide produced better blood glucose control and body weight improvements with reduced risk of hypoglycemia, compared to degludec in these patients.
rheumatoid arthritis | Research | Treatment | 10 pages | source: Arthritis Care & Research | Added Oct 31, 2021
Can treatments for rheumatoid arthritis decrease responses to vaccinations?
lung cancer | Research | 7 pages | source: Annals of oncology | Added Oct 31, 2021
Not just a man's world; association between testosterone and cancer prognosis in men and women
The authors evaluated the association between testosterone levels and prognosis after cancer diagnosis in men and women.
diabetes mellitus | Research | 9 pages | source: Diabetes Care | Added Oct 30, 2021
Do race and ethnicity affect inflammation levels and the occurrence of early chronic kidney disease in diabetes?
This study investigated whether race and ethnicity affect inflammation levels in diabetes patients The authors also investigated whether inflammation levels were associated with early chronic kidney disease.
rheumatoid arthritis | Research | 6 pages | source: PLOS ONE | Added Oct 29, 2021
Can blood markers predict rheumatoid arthritis-associated interstitial lung disease?
This study investigated whether specific blood markers can predict if patients will be affected by rheumatoid arthritis-associated interstitial lung disease (RA-IDL).
lung cancer | Research | Treatment | 7 pages | source: PLOS ONE | Added Oct 29, 2021
Icotinib is a safe and effective treatment for non-small-cell lung cancer
This study explored the use of icotinib as a first-line treatment for epidermal-growth-factor receptor positive non-small cell lung cancer.
diabetes mellitus | Research | 9 pages | source: The Journal of clinical endocrinology and metabolism | Added Oct 28, 2021
Diabetes in the long run: What predicts complications?
The current study examined the long-term complications, including the need for renal replacement therapy and mortality, of type 1 diabetes.
rheumatoid arthritis | Research | Treatment | 10 pages | source: The Journal of Rheumatology | Added Oct 27, 2021
Impact of 5-year baricitinib treatment for active, rheumatoid arthritis in preventing radiographic progression of joint damage.
This study evaluated the effect of oral baricitinib (Olumiant) on the prevention of radiographic progression of joint damage over 5 years in patients with active rheumatoid arthritis (RA). The data showed that patients treated with oral baricitinib had less radiographic progression over 5 years, compared to those initially given a conventional synthetic disease-modifying antirheumatic drug (csDMARD) and placebo or methotrexate (MTX; Otrexup) alone.
hypertension | Research | Treatment | 10 pages | source: Hypertension | Added Oct 26, 2021
Is renal denervation a safe and effective treatment for resistant hypertension?
This study examined the safety and effectiveness of renal denervation compared to intense drug treatment for resistant hypertension. The authors concluded that renal denervation achieved a decrease in blood pressure similar to that seen with intense drug treatment.
diabetes mellitus | Research | Treatment | 10 pages | source: Endocrine | Added Oct 26, 2021
Do insulin analogues differ in effectiveness and safety for the treatment of diabetes?
This study assessed the effectiveness and safety of different long-acting and short-acting insulins for the treatment of patients with diabetes. The data supported the use of long-acting insulins instead of neutral protamine Hagedorn (NPH) insulin (Humulin N; Novolin N), as basal insulin for patients with type 2 diabetes (T2D).
